Effects of  CCR5  59029G/A polymorphism on the risk to diabetic nephropathy

Mingfeng Cao; Zhenhua Tian; Lin Zhang; Ruiting Liu; Qingbo Guan; Jinjiao Jiang

doi:10.18632/oncotarget.22148

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Effects of CCR5 59029G/A polymorphism on the risk to diabetic nephropathy

Mingfeng Cao, Zhenhua Tian, Lin Zhang, Ruiting Liu, Qingbo Guan and Jinjiao Jiang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:106926-106934. https://doi.org/10.18632/oncotarget.22148

Metrics: PDF 1118 views | HTML 2189 views | ?

Abstract

Mingfeng Cao1, Zhenhua Tian1, Lin Zhang1, Ruiting Liu1, Qingbo Guan1 and Jinjiao Jiang1

1Department of Endocrinology, Shandong Provincial Hospital Affilated to Shandong University, Jinan 250100, Shandong, China

Correspondance to:

Jinjiao Jiang, email: [email protected]

Keywords: CCR5; chemokine; diabetic nephropathy; polymorphism; meta-analysis

Received: July 02, 2016 Accepted: June 13, 2017 Published: October 30, 2017

ABSTRACT

Background: Diabetic nephropathy (DN) causes high mortality in patients with diabetes mellitus and imposes heavy burden on individuals and society. In previous studies, various researches have investigated the association of DN with CCR5 59029G/A polymorphism, but relevant findings were controversial. Therefore, we performed this meta-analysis to obtain a conclusion on this issue.

Results: CCR5 59029G/A polymorphism showed significant risk-increasing effects on DN in all analyses under AA vs. GG, AA+GA vs. GG, AA vs. GG+GA, A vs. G and GA vs. GG model contrasts. Besides, a similar result was also obtained in Asian and type 2 diabetes mellitus groups under these five contrasts after subgroup analyses.

Methods: The relevant publications were searched from the electronic databases and other sources. The association intensity between CCR5 59029G/A polymorphism and DN susceptibility was measured using pooled odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs). Inter-study heterogeneity was inspected with Q test, and sensitivity analysis was conducted to verify the stability of the final outcomes by removing one study each time in turn. Begg’s funnel plot and Egger’s test were utilized to examine publication bias among selected studies.

Conclusion: CCR5 59029G/A polymorphism is significantly related to enhanced susceptibility to DN, especially in Asian populations and people with type 2 diabetes mellitus.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22148

Publication Alerts

Research Papers:

Effects of CCR5 59029G/A polymorphism on the risk to diabetic nephropathy

Abstract